Neoplasia/BPH

	Ferroptosis-autophagy crosstalk in bladder cancer: mechanisms and therapeutic implications. Mol Cancer Wang Y, Wu N, Zhang S. PMID: 41736076 [PubMed - as supplied by publisher]
	Global, regional, and national burden of early-onset prostate cancer, 1990-2021: a systematic analysis for the global burden of disease study 2021. World J Surg Oncol Ma Y, Liu Y, Liu Y, Li J, Wu B, Yu W, Yang C. PMID: 41736007 [PubMed - as supplied by publisher]
	Robot-Assisted Versus Standard Laparoscopic Radical Nephrectomy for Renal Tumors: An Updated Systematic Review And Meta-Analysis with Meta-Regression. J Robot Surg Amin F, Abid A, Afzal T, Ghani ASUR, Hassan T, Azam AR, Awadallah SM, Naseer M, Mohib K, Khalid A. PMID: 41735697 [PubMed - in process]
	Comparative efficacy of nephron-sparing surgery versus total nephrectomy on operative and prognostic results in pT2 kidney tumors: a meta-analysis. J Robot Surg Zhou XY, Gou LY, Qin J, Gan SM, Yin JY, Cao S, Li HY, Huang HT, Li QL, Yang XS. PMID: 41735625 [PubMed - in process]
	Physical Activity, Trust, and Research Participation Among Men From Minority Ethnic Backgrounds Living With Prostate Cancer: A Qualitative Study. Psychooncology Carr J, Faghy MA, Broom D, Roscoe C, Williams K, Ashton REM. PMID: 41735200 [PubMed - indexed for MEDLINE]
	Re: Active Monitoring, Surgery, and Radiotherapy for Cribriform-positive and Cribriform-negative Prostate Cancer: A Secondary Analysis of the PROTECT Randomized Clinical Trial. Eur Urol Bratt O, Egevad L. PMID: 41735149 [PubMed - as supplied by publisher]
	The path forward for T cell engagers in patients with prostate cancer. J Immunother Cancer Subudhi SK, Siddiqui BA, Zarrabi KK, Kelly WK, Drake CG. PMID: 41734994 [PubMed - indexed for MEDLINE]
	Molecular and histopathological insights into renal neuroendocrine tumors (RenNETs): A comprehensive study. Pathol Res Pract Zhang K, Chen T, Wu X, Wu R, Chen B, Shi J, Xu Y, Fan X, Fu Y. PMID: 41734604 [PubMed - as supplied by publisher]
	Histone lactatation-related genes GPR19 and SLC22A16 are important diagnostic markers and drug treatment targets for prostate cancer. Genes Genomics Yan Y, Li Z, Ye M, Li J. PMID: 41733804 [PubMed - as supplied by publisher]
	Comparative Efficacy and Toxicity of Gemcitabine-Cisplatin vs. Gemcitabine-Carboplatin in Metastatic Carcinoma of the Urinary Bladder: A Retrospective Review. Gulf J Oncolog Goel V, Jain A, Basu D, Patnaik N, Talwar V, Swamy S, Rawal S. PMID: 41733168 [PubMed - indexed for MEDLINE]
	Glycolysis-related genes for bladder cancer: A Mendelian randomization analysis. Biochem Biophys Rep Hong X, Wang G, Hong T, Liu X, Lin S, Liu G, Lin W, Zhang Y. PMID: 41732417 [PubMed]
	Metastatic renal cell carcinoma: risk of rapid progression to pathological fractures and factors influencing post-treatment survival - a Swedish Nationwide cohort study. J Bone Oncol Åkerstedt J, Åström T, Wennergren D, Wänman J. PMID: 41732251 [PubMed]
	Association between dose to specific pelvic substructures and urinary and sexual dysfunction following Single-Dose ablative radiotherapy for prostate Cancer: A post hoc analysis from the ABRUPT trial. Clin Transl Radiat Oncol Arcangeli S, Faccenda V, Ferrario F, Chissotti C, De Sanctis L, Rossano G, Arcieri E, Pisoni V, Colciago RR, De Ponti E, Panizza D. PMID: 41732214 [PubMed]
	Steroidogenesis inhibitor opevesostat (MK-5684) for metastatic castration-resistant prostate cancer: OMAHA-003 and OMAHA-004 trial designs. Future Oncol Yu EY, Gratzke C, Burotto M, Zhang AY, Lévesque E, Ortega F, Peer A, Vile D, Chen ZH, Song Y, Schloss C, Todoric J, Garratt C, Poehlein C, Antonarakis ES, Fizazi K. PMID: 41732008 [PubMed - as supplied by publisher]
	Effect of Neoadjuvant Chemo-Hormonal Therapy on Reducing Recurrence in Patients With Very High-Risk Prostate Cancer Undergoing Robot-Assisted Radical Prostatectomy. Int J Urol Koyama Y, Morizane S, Moriyasu E, Hoshino T, Yamamoto A, Omatsu R, Yamane H, Makishima K, Nishikawa R, Kimura Y, Yamaguchi N, Hikita K, Umekita Y, Takenaka A. PMID: 41731919 [PubMed - indexed for MEDLINE]
	A Dual-Hue Recognizable Lateral Flow Immunoassay Corresponding to Distinct Sensitivity Ranges for Timely and Quantitative Diagnosis of Prostate Cancer. ACS Nano Hu R, Zhang X, Huang L, Hu J, Wang J. PMID: 41730849 [PubMed - as supplied by publisher]
	Beyond Chronologic Age: Frailty, Geriatric Assessment, and Personalized Care for Older Adults With Genitourinary Cancer. Am Soc Clin Oncol Educ Book Lee PL, Fitch C, Efstathiou JA, Garg T. PMID: 41730161 [PubMed - indexed for MEDLINE]
	Survival study of cytoreductive prostatectomy for prostate cancer with lung metastasis: A propensity score matching study based on the SEER database. PLoS One Xiang AP, Yuan XF, Qin ZQ. PMID: 41729968 [PubMed - indexed for MEDLINE]
	Acquisition, image quality, and PI-RADS agreement of ultrahigh-gradient DWI in prostate 3-T MRI. Eur Radiol Exp Bischoff LM, Endler C, Krausewitz P, Ellinger J, Klümper N, Isaak A, Mesropyan N, Kravchenko D, Kuetting D, Sprinkart AM, Mürtz P, Pieper CC, Luetkens JA. PMID: 41729479 [PubMed - indexed for MEDLINE]
	The efficacy and safety of 1470Â nm diode laser in the treatment of benign prostatic hyperplasia: a prospective, multicenter study. Lasers Med Sci Xu H, Kuang W, Lin D, Li K, Luan Y, Cui K, Yang T, Chen Z. PMID: 41729325 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 185762

Page 1 of 9289



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy